Psychedelinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Decriminalization, Legalization, & State Efforts
Maine Senate Approves Medical Psilocybin Bill, But House Refusal Kills Measure For The Year
MARIJUANA MOMENT
The Maine Senate this week approved a bill to to create a medical psilocybin program in the state, but the House of Representatives refused to go along. The legislation from Sen. Donna Bailey (D), which was introduced around this time last year, would have allowed adults 21 and older to access the p…
The Maine Senate this week approved a bill to to create a medical psilocybin program in the state, but the House of Representatives refused to go along. The legislation from Sen. Donna Bailey (D), which was introduced around this time last year, would have allowed adults 21 and older to access the p…
Oregon Psilocybin Services Act
Oregon Has Legalized Psilocybin Therapy—So When Can I Take Magic Mushrooms?
PORTLAND MERCURY
It’s T-minus 259 days until Oregonians can legally start tripping, and we’re still deciding how best to manage the production and administration of psychedelic drugs. In 2020, voters passed Measure 109, permitting the use of psilocybin, the active ingredient in magic mushrooms. In the months since,…
It’s T-minus 259 days until Oregonians can legally start tripping, and we’re still deciding how best to manage the production and administration of psychedelic drugs. In 2020, voters passed Measure 109, permitting the use of psilocybin, the active ingredient in magic mushrooms. In the months since,…
Research, Therapy, & Science
A psychedelic therapist allegedly took millions from a Holocaust survivor, highlighting worries about elders taking hallucinogens
STAT NEWS
“It’s a whole new frightening possibility of elder abuse,” a geriatric psychiatrist said about the risks faced by older people treated with psychedelics.
“It’s a whole new frightening possibility of elder abuse,” a geriatric psychiatrist said about the risks faced by older people treated with psychedelics.
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
BENZINGA
If you’re just now considering the therapeutic value of psychedelics, Cybin Inc (NYSE: CYBN) is many trips ahead of you.
If you’re just now considering the therapeutic value of psychedelics, Cybin Inc (NYSE: CYBN) is many trips ahead of you.
Psychedelic-assisted therapy is coming — just not to Africa
SAN FRANCISCO CHRONICL
There is an epidemic of mental illness in sub-Saharan Africa. Magic mushrooms could...
There is an epidemic of mental illness in sub-Saharan Africa. Magic mushrooms could...
The Trials and Tribulations of Psychedelic Research
MICRODOSE
This article provides a brief overview of the Food and Drug Administration’s (FDA) regulatory scheme around drug development, future clinical research of psychedelics, and legal challenges in this emerging area.
This article provides a brief overview of the Food and Drug Administration’s (FDA) regulatory scheme around drug development, future clinical research of psychedelics, and legal challenges in this emerging area.
Psilocybin, the active ingredient in ‘magic mushrooms,’ makes scientific gains
CHANGING AMERICA
Story at a glance Studies over the past several years have shown promise in using psilocybin-assisted therapy to treat psychiatric disorders like depression. A recent follow-up study by Johns Hopki…
Story at a glance Studies over the past several years have shown promise in using psilocybin-assisted therapy to treat psychiatric disorders like depression. A recent follow-up study by Johns Hopki…
Business
Sanofi Strikes Deal With Mysterious Psychedelics Biotech Terran
BIOSPACE
New York-based Terran Biosciences inked a deal with Paris-based Sanofi for two late-stage central nervous system (CNS) assets. Terran plans to advance them for neurological and psychological indications.
New York-based Terran Biosciences inked a deal with Paris-based Sanofi for two late-stage central nervous system (CNS) assets. Terran plans to advance them for neurological and psychological indications.
Nue Life Health raises $23M Series A Led by Obvious Ventures for psychedelics platform
TECH CRUNCH
Last year we covered the $3.3 million seed round for NUE Life Health, a US-based telemedicine startup in the US, which was building out a mental wellness platform that combined psychedelic-assisted therapies and a graph database-driven app. This at-home ketamine therapy – considered a radical…
Last year we covered the $3.3 million seed round for NUE Life Health, a US-based telemedicine startup in the US, which was building out a mental wellness platform that combined psychedelic-assisted therapies and a graph database-driven app. This at-home ketamine therapy – considered a radical…
EXCLUSIVE: Why Kevin O’Leary Of ‘Shark Tank’ Says Public Psychedelics Companies Will Need To Merge
BENZINGA
The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday.
The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday.
Who Really “Owns” the Psychedelics Market?
GREEN MARKET REPORT
The psychedelics renaissance that began in earnest a few years ago is showing itself to be a darling of biotech investors who see a great future ahead for psychedelics as a treatment for many mental health disorders, depression chief among them. But really, who actually “owns” the psychedelics marke…
The psychedelics renaissance that began in earnest a few years ago is showing itself to be a darling of biotech investors who see a great future ahead for psychedelics as a treatment for many mental health disorders, depression chief among them. But really, who actually “owns” the psychedelics marke…
Culture
NFL Day-Tripper Kenny Stills Is Embracing the Healing Power of Using Psychedelics
INSIDE HOOK
Stills is the first active NFL player to openly talk about his use of psychedelics, including psilocybin and ketamine
Stills is the first active NFL player to openly talk about his use of psychedelics, including psilocybin and ketamine
Upcoming Events
PSYCHEDELIC BAR ASSOCIATION
The Psychedelics Bar Association is an association of accomplished attorneys from all practice areas and perspectives -- corporate, constitutional, intellectual property and regulatory attorneys, impact litigators, in-house counsel, policy analysts, and criminal justice reformers -- dedicated to sol…
FREE Virtual Event Series - Deep Dive Into Oregon Psilocybin Services Act: Business Formation and IRC 280E (Session 4).
EMERGE LAW GROUP
Our fourth session of our Deep Dive series will focus on business formation, and unique issues that arise when operating in a legal grey area, including IRC 280E.
Our fourth session of our Deep Dive series will focus on business formation, and unique issues that arise when operating in a legal grey area, including IRC 280E.
Subscribe
Subscribe to Psychedelinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
